ENCEFA Alternatives & Competitors
12 companies similar to ENCEFA — ENCEFA, a longevity company that reprogram suffering cells and activated immune...
Companies similar to ENCEFA
REGENXBIO
Seeking to improve lives through the curative potential of gene therapy.
Mimio Health
Harness your biology with clinically-validated biomimetic cell care. Nature designed. Mimi...
Lysoway Therapeutics
Leading the way in lysosomal ion channel biology to address neurodegenerative diseases and...
Rejuvenate Bio
Targeting the core drivers of chronic age-related diseases to reverse pre-existing conditi...
Rival Readout
Competing with ENCEFA? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Refoxy Pharma
Discovering medicines to treat age-related diseases and extend the years of healthy living
Locanabio, Inc.
Creating RNA-targeting gene therapies to treat devastating diseases
Aspect Biosystems
Developing Bioprinted Tissue Therapeutics to transform how we treat some of the most elusi...
Biophysical Therapeutics
Computational biology to design new drugs.
Dx Biosamples, LLC
Providing the highest quality of human biospecimens to the Global Life Science Community!
Cerevance
Cerevance a neuroscience company
Senolytx
STX develops medicines targeting damaged cells to improve human health and advance therapi...
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
About ENCEFA
ENCEFA, founded in 2016 and headquartered in France, is a biotechnology company pioneering cell rejuvenation therapies for age-related diseases. Their innovative approach involves developing novel CD38 modulators that enhance cellular autophagy and energy metabolism, addressing cellular senescence—a key component in ag...
development and offering of online slot games, bonus and loyalty programs, game optimization for mobile devices
online gamblers, slot machine enthusiasts, mobile gamers, players seeking high RTP and jackpots, loyalty program participants
Longevity, CD38 Modulators, Anti-aging Biotechnology, Neurodegenerative Diseases, Amyotrophic Lateral Sclerosis (ALS), Metabolic Disorders, Immune System Rejuvenation, NAD+ Levels Boost, Intracellular Clearance Activation, Energy Metabolism Enhancement, Organ Protection, Biopharmaceuticals, Autophagy-Lysosomal Flux Activation, Inflammation Repair, Tissue Protection
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around ENCEFA: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at ENCEFA on 3 Apr 2026. The 12 companies listed here were last checked between 25 Jul 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.